Neogenomics Inc (NASDAQ:NEO)
| 21.90 Delayed Data As of Jan 20 |  -0.64 / -2.84%Today’s Change | 21.78 Today|||52-Week Range 61.57 | -35.81% Year-to-Date |
Latest NEO News | Press Releases
No recent news for Neogenomics Inc.
Today’s Trading
| Previous close | 22.52 |
| Today’s open | 22.70 |
| Day’s range | 21.78 - 23.84 |
| Volume | 1,965,246 |
| Average volume (3 months) | 1,031,861 |
| Market cap | $3.1B |
Data as of 4:00pm ET, 01/20/2022
Growth & Valuation
| Earnings growth (last year) | -51.82% |
| Earnings growth (this year) | -275.76% |
| Earnings growth (next 5 years) | -61.11% |
| Revenue growth (last year) | +8.71% |
| P/E ratio | 52.1 |
| Price/Sales | 13.54 |
| Price/Book | 4.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVTAInvitae Corp | +0.12 | +1.05% |
| ---- | ||
| FLGTFulgent Genetics Inc | -2.43 | -3.51% |
| RDNTRadNet Inc | +0.21 | +0.79% |
Data as of 4:40pm ET, 01/20/2022
Financials
| Next reporting date | February 23, 2022 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $444.4M |
| Annual profit (last year) | $4.2M |
| Net profit margin | 0.94% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Fort Myers, Florida |
Forecasts
